An Open Label Study to Evaluate Immunogenicity, Safety, and Reactogenicity of Rotavac® (Live Attenuated Rotavirus Vaccine) as a 3-dose Series in Healthy Infants Aged Between 6 Weeks and 8 Weeks in Vietnam
Phase of Trial: Phase III
Latest Information Update: 08 Mar 2018
At a glance
- Drugs Rotavirus vaccine (Primary)
- Indications Rotavirus infections
- Focus Adverse reactions
- 01 Mar 2018 Planned End Date changed from 1 May 2018 to 1 Dec 2018.
- 01 Mar 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Oct 2018.
- 13 Dec 2017 New trial record